Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

PT410 – Manufacturing MDMA and Why Creating MDMA Analogs Is So...

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Psychedelics Weekly – Multi-Stakeholder Capitalism, Psilocybin Service Centers Begin Opening in...

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol...

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs...

GH Research Reports First Quarter 2023 Financial Results and Provides Business...

Brain scanning technology to be used for clinical psychedelics trials in...

Sunstone Therapies to present data on the long-term efficacy of psilocybin...

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces...

Load more